A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
In this pilot study, we intend to demonstrate that a great portion of women at high risk
 (inadequate screening, HPV 16/18 and/or cytology) are presenting to the ED, cytology/ HPV
 testing via ThinPrep®Pap testTM and surveillance. We intend to provide improved access to
 healthcare and monitoring through administration of vaccine to eligible patients and 1 year
 follow up for patients involved in this study.

 Females meeting inclusion/exclusion criteria participating in the study (n=100) that have not
 had a cytology test in 2 or more years will be offered the Thin Prep® cytology test. This
 study will allow surveillance of disease through cytology and HPV DNA testing via collection
 of data using Thin Prep® cytology with reflex HPV DNA testing according to established
 guidelines as described below.

 Provide improved access to healthcare and monitoring through administration of vaccine for
 eligible females as established by guidelines. Patients will receive first vaccine in the ED
 and will have arranged follow up for administration of the 2 month and 6 month series of the
 HPV vaccination. Through data collection, we intend to determine if there is a need for
 vaccination and determine if patients are likely to follow up..
Inclusion Criteria:

 -  3 years of beginning sexual activity or by age 21 years whichever occur first.

 -  resident of the City of Norfolk, Virginia

 -  uninsured

 Exclusion Criteria:

 -  Pregnant women

 -  Women with Hysterectomy with cervical excision

 -  Women who received full HPV vaccine series

 -  Known history of cervical cancer

 -  Male sex

 -  Loop electrocautery excision procedure(LEEP)

 -  Cold-Knife conization